Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02534233 · ClinicalTrials.gov registry record · NA
Evaluation of Effect of CryoBalloon Focal Ablation System on Human Esophageal Epithelium
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
NCT02534233: Completed NA study, sponsored by Johns Hopkins University.
NCT02534233 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 58 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02534233, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
Study Summary
Assess Cryoablation (CryoBalloon Ablation cryotherapy) for treatment of Dysplastic Barrett's Esophagus, Esophageal Squamous Dysplasia and early Esophageal Cancer. The cryoablation treatment will be offered as an alternative to standard ablation therapies such as Radiofrequency Ablation, Argon Plasma Coagulation and carbon dioxide Cryotherapy).
Interventions
- DEVICE CryoBalloon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2015-04 |
| Est. Completion | 2025-02-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02534233
The ClinicalTrials.gov registry entry for NCT02534233 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CryoBalloon is the first listed.
NCT02534233 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02534233 about?
NCT02534233 is a clinical study titled "Evaluation of Effect of CryoBalloon Focal Ablation System on Human Esophageal Epithelium". Assess Cryoablation (CryoBalloon Ablation cryotherapy) for treatment of Dysplastic Barrett's Esophagus, Esophageal Squamous Dysplasia and early Esophageal Cancer. The cryoablation treatment will be offered as an alternative to standard ablation therapies such as Radiofrequency Ablation, Argon Plasma...
What is the current status of trial NCT02534233?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2015-04. Estimated completion is 2025-02-27.
What interventions are being tested in trial NCT02534233?
The interventions under investigation include: CryoBalloon (DEVICE).
Who is sponsoring clinical trial NCT02534233?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.